Have the roles of two functional polymorphisms in breast cancer, R72P in P53 and MDM2-309 in MDM2, become clearer?

被引：0
|
作者：
Rodney J Scott
机构：
[1] John Hunter Hospital,Discipline of Medical Genetics, Faculty of Health, University of Newcastle, Newcastle, NSW 2308, Australia; Centre for Information Based Medicine, Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW 2305, Australia;
来源：
Breast Cancer Research | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Genetic differences between individuals have been predicted to account for disparate outcomes in patients diagnosed with cancer. The search for genetic determinants has been ongoing for a considerable amount of time and it is only now that insights have been gained into which polymorphisms are most likely to be important in determining not only disease likelihood but also outcome. The quest to be able to accurately predict patient outcomes in breast cancer may now be a step closer as increased sample size is leading to more robust statistical analysis and a better understanding of molecular mechanisms of disease are forthcoming.
引用
收藏
相关论文
共 50 条
  • [41] MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
    Zhou, X.
    Rock, J.
    McNally, M. E.
    Bloomston, M.
    Zhao, W.
    Lozanski, G.
    Frankel, W. L.
    MODERN PATHOLOGY, 2012, 25 : 450A - 450A
  • [42] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [43] MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
    Zhou, X.
    Rock, J.
    McNally, M. E.
    Bloomston, M.
    Zhao, W.
    Lozanski, G.
    Frankel, W. L.
    LABORATORY INVESTIGATION, 2012, 92 : 450A - 450A
  • [44] Inorganic arsenic induces MDM2, p53, and their phosphorylation and affects the MDM2/p53 complex in vitro
    Yin, Jinyao
    Zhou, Qian
    Tan, Jingwen
    Che, Wangjun
    He, Yuefeng
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (58) : 88078 - 88088
  • [45] Inorganic arsenic induces MDM2, p53, and their phosphorylation and affects the MDM2/p53 complex in vitro
    Jinyao Yin
    Qian Zhou
    Jingwen Tan
    Wangjun Che
    Yuefeng He
    Environmental Science and Pollution Research, 2022, 29 : 88078 - 88088
  • [46] Gene Polymorphisms Of P53 At Codon 72 And Mdm2 Snp309 Are Associated With Emphysematous Changes In COPD Patients
    Mizuno, S.
    Ishizaki, T.
    Kadowaki, M.
    Gomez-Arroyo, J. G.
    Kraskauskas, D.
    Voelkel, N. F.
    Osanai, K.
    Toga, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [47] The expression of MDM2 and p53 protein breast carcinoma
    Hideshima, T
    Shinohara, T
    Baba, M
    Shirakusa, T
    ONCOLOGY REPORTS, 1997, 4 (02) : 297 - 300
  • [48] Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility?: A large pooled series from the breast cancer association consortium
    Schmidt, Marjanka K.
    Reincke, Scarlett
    Broeks, Annegien
    Braaf, Linde M.
    Hogervorst, Frans B. L.
    Tollenaar, Rob A. E. M.
    Johnson, Nichola
    Fletcher, Olivia
    Peto, Julian
    Tommiska, Johanna
    Blomqvist, Carl
    Nevanlinna, Heli A.
    Healey, Catherine S.
    Dunning, Alison M.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Dork, Thilo
    Van't Veer, Laura J.
    CANCER RESEARCH, 2007, 67 (19) : 9584 - 9590
  • [49] MDM2 SNP 309 and p53 mutations in metastatic malignant melanoma
    Busch, Christian
    Geisler, Jurgen
    Lillehaug, Johan
    Lonning, Per
    CANCER RESEARCH, 2008, 68 (09)
  • [50] MDM2 AND P53 - A QUESTION OF BALANCE
    MELTZER, PS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1265 - 1266
12345